Search

everythinglearnresearchcommunity

for

Search:↓

The dog with an Alopecia Areata-like condition showed signs of an autoimmune disease and partially regrew hair without treatment, suggesting dogs could be models for human AA research.

A patient with total hair loss developed vitiligo after using a treatment called DCP.

Restoring immune privilege in hair follicles could help treat certain types of hair loss.

Intralesional triamcinolone acetonide effectively treats alopecia areata, as shown by significant improvements in hair regrowth and dermoscopic indicators.

Norwegian puffin dogs have a unique type of hair loss that often doesn't get better on its own and responds well to ciclosporin treatment.

Dermatologists' treatment of alopecia areata is inconsistent, especially for children and advanced stages.

Microneedling with minoxidil improved hair growth in elderly man.

Differences in gene expression and methylation patterns found in AGA patients suggest potential targets for future treatments.

A woman with Kallman's syndrome also developed alopecia universalis, a condition not previously linked to Kallman's.

Certain genetic variants linked to immune response increase the risk of alopecia areata in Taiwanese people.

Alopecia in dogs is often caused by mange, flea and tick infestations, and nutritional deficiencies, especially in males and young dogs.

Many people suffer from hair loss, which is caused by a disruption in hair growth, and there is a need for personalized treatments and new drugs.

A 6-year-old girl with alopecia universalis regrew most of her hair after treatment with simvastatin/ezetimibe, minoxidil, and prednisolone.

Azathioprine may help treat severe alopecia areata, but more research is needed.

Microneedling with PRP is a safe and effective way to treat chronic alopecia areata, improving hair regrowth with minimal side effects.

Diagnosing alopecia areata is challenging and requires careful examination and various tests to distinguish it from other hair loss types.

Most bald men don't protect their scalp from the sun, and doctors should encourage prevention.

Hair loss improved with treatment and successful transplant.

The Polish Society of Dermatology recommends treatments for alopecia areata that vary by severity, including topical and systemic medications, with long-term maintenance important for management.

Latanoprost is more effective than minoxidil for treating alopecia areata.

Baricitinib improves quality of life and reduces anxiety and depression in severe alopecia areata patients with hair regrowth.

Alopecia Areata significantly lowers quality of life and current treatments are inadequate, highlighting a need for better therapies and standardized treatment protocols.

In Denmark from 1995 to 2016, hospital-treated alopecia areata cases increased, mostly affecting women and those over 50.

Alopecia areata severely impacts quality of life, mental health, and work productivity.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

The study suggests that hypothyroidism may cause alopecia areata.

Both treatments for alopecia areata showed similar modest effectiveness.

Certain gut bacteria may protect against alopecia areata, while others may increase the risk.

Baricitinib is a new, effective treatment for advanced alopecia areata but is costly and has risks.

A woman with systemic sclerosis developed a unique scarring hair loss combining features of systemic sclerosis and frontal fibrosing alopecia.